SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.160+2.7%Jan 16 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Straynut who wrote (10043)4/13/2018 4:18:35 PM
From: BoredMember1 Recommendation

Recommended By
Another_Voice_2

  Read Replies (1) of 12873
 
Great News! Initial non-GLP toxicology completed!

Drugs being developed for multiple indications and market size is in the 10's of Billions!

Being developed for topical use at site of infection! Direct and fast.

Dr. Eugene Seymour left us in great shape. His dedication, commitment, and tireless hours of hard work will finally pay off for us. We should all thank him for his efforts, successes and never ending desire to keep us and the world aware of all the great progress Nanoviricides is making.

Thank you Dr. Eugene Seymour!

This is our year!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News